Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers

Cancer Biology and Therapy

Volumn 13, Issue 11, 2012, Pages 992-1000

  David, Gregory ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chromatin; Histone modification; Methylation; SAHF; SASP; Senescence; Transcription

Indexed keywords

ATM PROTEIN; DNA; HISTONE H3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; UNTRANSLATED RNA;

CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CHROMATIN; DNA DAMAGE; GENE ACTIVATION; GENE LOCUS; GENETIC ANALYSIS; HETEROCHROMATIN; HISTONE MODIFICATION; HUMAN; NONHUMAN; ONCOGENE; PHENOTYPE; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL CYCLE; CHROMATIN; GENE EXPRESSION REGULATION; HUMANS; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 84865859357     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.21116     Document Type: Review

References (97)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233.
2. Dimauro T, David G. Ras-induced senescence and its physiological relevance in cancer. Curr Cancer Drug Targets 2010; 10:869-76; PMID:20718709; http://dx.doi.org/10.2174/156800910793357998.
3. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621; http://dx.doi.org/10.1016/0014-4827(61) 90192-6.
4. Campisi J. Replicative senescence: an old lives' tale? Cell 1996; 84:497-500; PMID:8598035; http://dx.doi.org/10.1016/S0092-8674(00)81023-5.
5. Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371:21-31; PMID:17634571; http://dx.doi.org/10.1007/978-1-59745-361-5-3.
6. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/ 10.1073/pnas.92.20.9363.
7. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602; PMID:9054499; http://dx.doi.org/10.1016/S0092-8674(00) 81902-9.
8. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 2006; 5:187-95; PMID:16626397; http://dx.doi.org/10.1111/j.1474-9726.2006. 00199.x.
9. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642; PMID:16079833; http://dx.doi.org/10.1038/436642a.
10. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91:649-59; PMID:9393858; http://dx.doi.org/10. 1016/S0092-8674(00)80452-3.
11. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996; 93:13742-7; PMID:8943005; http://dx.doi.org/10.1073/pnas.93.24.13742.
12. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114:1299-307; PMID:15520862.
13. Narita M, Nünez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703-16; PMID:12809602; http://dx.doi.org/10. 1016/S0092-8674(03)00401-X.
14. Funayama R, Saito M, Tanobe H, Ishikawa F. Loss of linker histone H1 in cellular senescence. J Cell Biol 2006; 175:869-80; PMID:17158953; http://dx.doi.org/10.1083/jcb.200604005.
15. Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126:503-14; PMID:16901784; http://dx.doi.org/10.1016/j.cell.2006.05.052.
16. Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2343-58; PMID:17242207; http://dx.doi.org/10.1128/MCB.02019-06.
17. Dimri GP, Itahana K, Acosta M, Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol 2000; 20:273-85; PMID:10594030; http://dx.doi.org/10. 1128/MCB.20.1.273-85.2000.
18. Rowland BD, Denissov SG, Douma S, Stunnenberg HG, Bernards R, Peeper DS. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2002; 2:55-65; PMID:12150825; http://dx.doi.org/10.1016/S1535-6108(02)00085-5.
19. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7; PMID:17136093; http://dx.doi.org/10.1038/nature05268.
20. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10. 1038/nature05327.
21. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21:43-8; PMID:17210786; http://dx.doi.org/10.1101/gad.1487307.
22. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133:1006-18; PMID:18555777; http://dx.doi.org/10.1016/j.cell.2008.03.038.
23. Augert A, Payré C, de Launoit Y, Gil J, Lambeau G, Bernard D. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep 2009; 10:271-7; PMID:19197340; http://dx.doi.org/10.1038/embor.2008.255.
24. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006; 8:877-84; PMID:16862142; http://dx.doi.org/10. 1038/ncb1448.
25. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-31; PMID:18555778; http://dx.doi.org/10.1016/j.cell.2008.03.039.
26. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132:363-74; PMID:18267069; http://dx.doi.org/10.1016/ j.cell.2007.12.032.
27. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11:973-9; PMID:19597488; http://dx.doi.org/10.1038/ncb1909.
28. Bertram MJ, Bérubé NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, et al. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 1999; 19:1479-85; PMID:9891081.
29. Hayakawa T, Ohtani Y, Hayakawa N, Shinmyozu K, Saito M, Ishikawa F, et al. RBP2 is an MRG15 complex component and downregulates intragenic histone H3 lysine 4 methylation. Genes Cells 2007; 12:811-26; PMID:17573780.
30. Pardo PS, Leung JK, Lucchesi JC, Pereira-Smith OM. MRG15, a novel chromodomain protein, is present in two distinct multiprotein complexes involved in transcriptional activation. J Biol Chem 2002; 277:50860-6; PMID:12397079; http://dx.doi.org/10.1074/jbc.M203839200.
31. Yochum GS, Ayer DE. Role for the mortality factors MORF4, MRGX and MRG15 in transcriptional repression via associations with Pf1, mSin3A and Transducin-Like Enhancer of Split. Mol Cell Biol 2002; 22:7868-76; PMID:12391155; http://dx.doi.org/10.1128/MCB.22.22.7868-76.2002.
32. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005; 123:581-92; PMID:16286007; http://dx.doi.org/10.1016/j.cell.2005.10.023.
33. Joshi AA, Struhl K. Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation. Mol Cell 2005; 20:971-8; PMID:16364921; http://dx.doi.org/10.1016/j.molcel.2005.11.021.
34. Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR, et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 2005; 123:593-605; PMID:16286008; http://dx.doi.org/10.1016/j.cell.2005.10.025.
35. Chen M, Tominaga K, Pereira-Smith OM. Emerging role of the MORF/MRG gene family in various biological processes, including aging. Ann NY Acad Sci 2010; 1197:134-41; PMID:20536842; http://dx.doi.org/10.1111/j.1749-6632.2010.05197.x.
36. Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, et al. ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol 2005; 25:6639-48; PMID:16024799; http://dx.doi.org/10.1128/MCB.25.15.6639-48.2005.
37. Zhang K, Dent SY. Histone modifying enzymes and cancer: going beyond histones. J Cell Biochem 2005; 96:1137-48; PMID:16173079; http://dx.doi.org/10. 1002/jcb.20615.
38. Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005; 8:19-30; PMID:15621527; http://dx.doi.org/10.1016/j.devcel.2004.10.019.
39. Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007; 397:84-93; PMID:17544228; http://dx.doi.org/10.1016/j.gene.2007.04.020.
40. Narita M. Cellular senescence and chromatin organisation. Br J Cancer 2007; 96:686-91; PMID:17311013; http://dx.doi.org/10.1038/sj.bjc.6603636.
41. Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schöfer C, et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001; 107:323-37; PMID:11701123; http://dx.doi.org/10.1016/S0092-8674(01)00542-6.
42. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-5; PMID:16079837; http://dx.doi.org/10.1038/ nature03841.
43. Kennedy AL, McBryan T, Enders GH, Johnson FB, Zhang R, Adams PD. Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Div 2010; 5:16; PMID:20569479; http://dx.doi.org/10.1186/1747-1028-5-16.
44. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13:292-302; PMID:21336312; http://dx.doi.org/10.1038/ncb2170.
45. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10:457-68; PMID:21248468; http://dx.doi.org/10.4161/cc.10.3.14707.
46. Ivanov A, Adams PD. A damage limitation exercise. Nat Cell Biol 2011; 13:193-5; PMID:21364567; http://dx.doi.org/10.1038/ncb0311-193.
47. Greenberg RA. Histone tails: Directing the chromatin response to DNA damage. FEBS Lett 2011; 585:2883-90; PMID:21621538; http://dx.doi.org/10.1016/j. febslet.2011.05.037.
48. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007; 102:1400-4; PMID:17979151; http://dx.doi.org/10. 1002/jcb.21609.
49. Blais A, Dynlacht BD. E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 2007; 19:658-62; PMID:18023996; http://dx.doi.org/10.1016/j.ceb.2007.10.003.
50. Korenjak M, Taylor-Harding B, Binné UK, Satterlee JS, Stevaux O, Aasland R, et al. Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes. Cell 2004; 119:181-93; PMID:15479636; http://dx.doi.org/10.1016/j.cell.2004.09.034.
51. Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, Botchan MR. Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex. Genes Dev 2004; 18:2929-40; PMID:15545624; http://dx.doi.org/10.1101/gad. 1255204.
52. Nagl NG Jr, Wang X, Patsialou A, Van Scoy M, Moran E. Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell cycle control. EMBO J 2007; 26:752-63; PMID:17255939; http://dx.doi.org/10.1038/sj. emboj.7601541.
53. Tyagi S, Chabes AL, Wysocka J, Herr W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol Cell 2007; 27:107-19; PMID:17612494; http://dx.doi.org/10.1016/j.molcel.2007.05.030.
54. Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev 2003; 17:896-911; PMID:12670868; http://dx.doi.org/10.1101/gad.252103.
55. Attwooll C, Oddi S, Cartwright P, Prosperini E, Agger K, Steensgaard P, et al. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner. J BiolChem 2005; 280:1199-208; PMID:15536069; http://dx.doi.org/10.1074/jbc.M412509200.
56. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 2002; 296:1132-6; PMID:12004135; http://dx.doi.org/10.1126/science. 1069861.
57. Litovchick L, Florens LA, Swanson SK, Washburn MP, DeCaprio JA. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev 2011; 25:801-13; PMID:21498570; http://dx.doi.org/10.1101/ gad.2034211.
58. Tschöp K, Conery AR, Litovchick L, Decaprio JA, Settleman J, Harlow E, et al. A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 2011; 25:814-30; PMID:21498571; http://dx.doi.org/10.1101/gad.2000211.
59. Dannenberg JH, van Rossum A, Schuijff L, teRiele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000; 14:3051-64; PMID:11114893; http://dx.doi.org/10.1101/gad.847700.
60. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14:3037-50; PMID:11114892; http://dx.doi.org/10.1101/gad.843200.
61. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, et al. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10. 1016/j.ccr.2010.01.023.
62. David G, Grandinetti KB, Finnerty PM, Simpson N, Chu GC, Depinho RA. Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci USA 2008; 105:4168-72; PMID:18332431; http://dx.doi.org/10.1073/pnas.0710285105.
63. Grandinetti KB, David G. Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal. Cell Cycle 2008; 7:1550-4; PMID:18469515; http://dx.doi.org/10.4161/cc.7.11.6052.
64. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 2002; 16:933-47; PMID:11959842; http://dx.doi.org/10.1101/gad.969202.
65. Grandinetti KB, Jelinic P, DiMauro T, Pellegrino J, Fernández Rodríguez R, Finnerty PM, et al. Sin3B expression is required for cellular senescence and is upregulated upon oncogenic stress. Cancer Res 2009; 69:6430-7; PMID:19654306; http://dx.doi.org/10.1158/0008-5472.CAN-09-0537.
66. Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, Hornsby PJ, et al. Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 2007; 6:577-91; PMID:17578512; http://dx.doi.org/10.1111/j.1474-9726.2007.00308.x.
67. Gonzalo S, García-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 2005; 7:420-8; PMID:15750587; http://dx.doi.org/10.1038/ncb1235.
68. Nijwening JH, Geutjes EJ, Bernards R, Beijersbergen RL. The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS One 2011; 6:25235; PMID:21980403; http://dx.doi.org/10.1371/journal.pone.0025235.
69. Peeper DS, Dannenberg JH, Douma S, teRiele H, Bernards R. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat Cell Biol 2001; 3:198-203; PMID:11175753; http://dx.doi.org/10.1038/35055110.
70. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583-94; PMID:20478252; http://dx.doi.org/10.1016/j.cell.2010.04.020.
71. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010; 141:69-80; PMID:20371346; http://dx.doi.org/10.1016/j.cell.2010.02. 027.
72. Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 2005; 576:22-38; PMID:15878778; http://dx.doi.org/10.1016/j.mrfmmm.2004.08. 021.
73. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85:27-37; PMID:8620534; http://dx.doi.org/10.1016/S0092-8674(00)81079-X.
74. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397:164-8; PMID:9923679; http://dx.doi.org/10.1038/16476.
75. Bernstein E, Duncan EM, Masui O, Gil J, Heard E, Allis CD. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol Cell Biol 2006; 26:2560-9; PMID:16537902; http://dx.doi.org/10.1128/MCB.26.7.2560-9.2006.
76. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38:662-74; PMID:20541999; http://dx.doi.org/10.1016/j.molcel.2010.03.021.
77. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21:525-30; PMID:17344414; http://dx.doi.org/10.1101/gad.415507.
78. Dietrich N, Bracken AP, Trinh E, Schjerling CK, Koseki H, Rappsilber J, et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 2007; 26:1637-48; PMID:17332741; http://dx.doi.org/10.1038/sj.emboj.7601632.
79. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007; 21:49-54; PMID:17210787; http://dx.doi.org/10.1101/gad.1499407.
80. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009; 10:697-708; PMID:19738629.
81. Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res 2011; 71:5365-9; PMID:21828241; http://dx.doi.org/10.1158/0008-5472.CAN-10-4379.
82. Barradas M, Anderton E, Acosta JC, Li S, Banito A, Rodriguez- Niedenführ M, et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 2009; 23:1177-82; PMID:19451218; http://dx.doi.org/10.1101/gad.511109.
83. Voncken JW, Niessen H, Neufeld B, Rennefahrt U, Dahlmans V, Kubben N, et al. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem 2005; 280:5178-87; PMID:15563468; http://dx.doi.org/10.1074/jbc.M407155200.
84. Kotake Y, Zeng Y, Xiong Y. DDB1-CUL4 and MLL1 mediate oncogene-induced p16INK4a activation. Cancer Res 2009; 69:1809-14; PMID:19208841; http://dx.doi.org/10.1158/0008-5472.CAN-08-2739.
85. Kia SK, Gorski MM, Giannakopoulos S, Verrijzer CP. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol 2008; 28:3457-64; PMID:18332116; http://dx.doi.org/10.1128/MCB.02019- 07.
86. Pfau R, Tzatsos A, Kampranis SC, Serebrennikova OB, Bear SE, Tsichlis PN. Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci USA 2008; 105:1907-12; PMID:18250326; http://dx.doi.org/10.1073/pnas.0711865105.
87. Tzatsos A, Pfau R, Kampranis SC, Tsichlis PN. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc Natl Acad Sci USA 2009; 106:2641-6; PMID:19202064; http://dx.doi.org/10.1073/pnas. 0813139106.
88. He J, Kallin EM, Tsukada Y, Zhang Y. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol Biol 2008; 15:1169-75; PMID:18836456; http://dx.doi.org/10.1038/nsmb.1499.
89. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-68; PMID:19053174; http://dx.doi.org/10.1371/journal.pbio.0060301.
90. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16:238-46; PMID:20444648; http://dx.doi.org/10.1016/j.molmed.2010.03.003.
91. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9:81-94; PMID:19132009; http://dx.doi.org/10.1038/ nrc2560.
92. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, et al. Control of the senescence-associated secretory phenotype by NFκB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125-36; PMID:21979375; http://dx.doi.org/10.1101/gad.17276711.
93. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr. Oncogenic Ha-Ras-induced signaling activates NFkappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997; 272:24113-6; PMID:9305854; http://dx.doi.org/10.1074/jbc.272.39.24113.
94. Sebastian T, Malik R, Thomas S, Sage J, Johnson PF. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J 2005; 24:3301-12; PMID:16107878; http://dx.doi.org/10.1038/sj.emboj.7600789.
95. Takahashi A, Imai Y, Yamakoshi K, Kuninaka S, Ohtani N, Yoshimoto S, et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Mol Cell 2012; 45:123-31; PMID:22178396; http://dx.doi.org/10.1016/j.molcel.2011.10.018.
96. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci USA 2009; 106:17031-6; PMID:19805069; http://dx.doi.org/10.1073/pnas.0905299106.
97. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10:51-7; PMID:20029423; http://dx.doi.org/10.1038/ nrc2772.